Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study

J Infect. 2021 Jun;82(6):276-316. doi: 10.1016/j.jinf.2021.02.011. Epub 2021 Feb 11.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19 Drug Treatment*
  • Humans
  • Lopinavir / therapeutic use
  • Ritonavir* / therapeutic use
  • SARS-CoV-2

Substances

  • Antiviral Agents
  • Lopinavir
  • Ritonavir